GP....if you are going to fire anyone,,,,,,lets have a lookie at existing RVX management,,,,,,not one step forward on any molecules sitting on the sideline for years.......our market cap at present is $200 million,,,,,17 years into this research and not one successful trial. Noted by the team, poor design of trials which caused the failure to meet endpoints when completion. Failure to launch any deal other than dilutions,,even giving the World HIV groups free access to RVX208 to eradicate aids completely,,,no takers,,,hummmm,,there has been so many complete and utter nothings generated by this company it has been a disgrace to every investor who was told by top management the following year is the one fellas,,the following year!

Yep,,, incompetance across the board as their track record clearly shows. The recent peer reviewed article is actually causing share price loss! Who would have thunk it?...well RVX investors would!! And if you think BTD is worth north of a $Billion,,well we should all think again,,because the market has told us otherwise!

Pay these managerial types a basic stipend and grant shares based on performance! You would see a business like model put in place so quickly it would spin ones head. This company is little more than a bank for those in control. They have yet to prove otherwise!,,,, This is my opinion.,,and I am very disappointed once again,,as management has no idea what is important or even how to improve share price!,,its plain pitiable!